Dynatronics Corporation (DYNT): Price and Financial Metrics


Dynatronics Corporation (DYNT): $0.71

0.07 (+10.83%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

DYNT Stock Summary

  • DYNT has a higher market value than only 1.32% of US stocks; more precisely, its current market capitalization is $13,262,401.
  • With a price/sales ratio of 0.29, Dynatronics Corp has a higher such ratio than merely 4.76% of stocks in our set.
  • With a year-over-year growth in debt of -51.31%, Dynatronics Corp's debt growth rate surpasses only 7.13% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Dynatronics Corp, a group of peers worth examining would be UFCS, JCTCF, EJH, TITN, and SAMG.
  • Visit DYNT's SEC page to see the company's official filings. To visit the company's web site, go to www.dynatronics.com.

DYNT Valuation Summary

  • DYNT's price/sales ratio is 0.5; this is 86.84% lower than that of the median Healthcare stock.
  • Over the past 243 months, DYNT's price/sales ratio has gone down 0.1.
  • Over the past 243 months, DYNT's price/sales ratio has gone down 0.1.

Below are key valuation metrics over time for DYNT.

Stock Date P/S P/B P/E EV/EBIT
DYNT 2021-08-31 0.5 1.0 -5.5 -8.8
DYNT 2021-08-30 0.5 1.0 -5.5 -8.9
DYNT 2021-08-27 0.5 1.0 -5.4 -8.7
DYNT 2021-08-26 0.5 0.9 -5.2 -8.5
DYNT 2021-08-25 0.5 1.0 -5.5 -8.8
DYNT 2021-08-24 0.5 1.0 -5.4 -8.6

DYNT Growth Metrics

    The 3 year revenue growth rate now stands at 111.87%.
  • The year over year net cashflow from operations growth rate now stands at -35.38%.
  • Its year over year net income to common stockholders growth rate is now at -76%.
Over the past 34 months, DYNT's revenue has gone down $17,430,126.

The table below shows DYNT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 46.52873 -4.658405 1.359578
2021-09-30 47.96678 -1.395919 2.076729
2021-06-30 47.79865 0.382963 1.209242
2021-03-31 43.67727 0.854752 -4.017446
2020-12-31 45.92317 2.80515 -5.278555
2020-09-30 49.15226 2.220871 -4.820737

DYNT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • DYNT has a Quality Grade of C, ranking ahead of 58.1% of graded US stocks.
  • DYNT's asset turnover comes in at 1.247 -- ranking 12th of 186 Medical Equipment stocks.
  • IRMD, ELMD, and NUVA are the stocks whose asset turnover ratios are most correlated with DYNT.

The table below shows DYNT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.247 0.270 0.109
2021-03-31 1.151 0.274 -0.133
2020-12-31 1.193 0.274 -0.178
2020-09-30 1.241 0.282 -0.145
2020-06-30 1.302 0.283 -0.118
2020-03-31 1.464 0.300 -0.046

DYNT Price Target

For more insight on analysts targets of DYNT, see our DYNT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $2.00 Average Broker Recommendation 1.33 (Strong Buy)

DYNT Stock Price Chart Interactive Chart >

Price chart for DYNT

DYNT Price/Volume Stats

Current price $0.71 52-week high $1.79
Prev. close $0.64 52-week low $0.43
Day low $0.62 Volume 47,700
Day high $0.71 Avg. volume 47,498
50-day MA $0.69 Dividend yield N/A
200-day MA $1.03 Market Cap 12.91M

Dynatronics Corporation (DYNT) Company Bio


Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. It offers orthopedic soft bracing products, which include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company also provides power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, treadmills, recumbent bikes, and other related equipment. In addition, it offers therapeutic modality devices, such as electrotherapy, ultrasound, phototherapy, therapeutic lasers, shortwave diathermy, radial pulse therapy, hot and cold therapy, compression therapy, and electrodes. Further, the company provides clinical supplies, including exercise bands and tubing, topical analgesics, lotions and gels, orthopedic bracing, paper products, athletic tapes, and other related supplies. It markets its products under the Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM brands. The company sells its products to orthopedists, physical therapists, chiropractors, and athletic trainers, sports medicine practitioners, hospitals, clinics, and consumers, as well as online. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Eagan, Minnesota.


DYNT Latest News Stream


Event/Time News Detail
Loading, please wait...

DYNT Latest Social Stream


Loading social stream, please wait...

View Full DYNT Social Stream

Latest DYNT News From Around the Web

Below are the latest news stories about Dynatronics Corp that investors may wish to consider to help them evaluate DYNT as an investment opportunity.

Dynatronics Corporation Reports Second Quarter Financial Results and Business Highlights

EAGAN, MN / ACCESSWIRE / February 10, 2022 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results and business highlights for its second quarter of fiscal year 2022 for the period ended December 31, 2021.CEO Commentary"Customer and dealer reaction to Dynatronics' business transformation strategy, combined with the favorable market environment, are driving sales to outpace the market for

Yahoo | February 10, 2022

Dynatronics Corporation Schedules Conference Call and Webcast to Provide Business Update and Discuss Second Quarter of Fiscal Year 2022 Results

EAGAN, MN / ACCESSWIRE / January 27, 2022 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its fiscal second quarter period ended December 31, 2021 on Thursday, February 10, 2022 before the market opens.The company will subsequently hold a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a quest

Yahoo | January 27, 2022

Dynatronics Corporation Announces Brian Baker as Chief Operating Officer

EAGAN, MN / ACCESSWIRE / January 19, 2022 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Brian Baker rejoined the company full-time as Chief Operating Officer effective on January 17, 2022. Baker joined Dynatronics as President of Therapy Products in February 2018.

Yahoo | January 19, 2022

Zacks Investment Research Downgrades Dynatronics (NASDAQ:DYNT) to Hold

Zacks Investment Research cut shares of Dynatronics (NASDAQ:DYNT) from a buy rating to a hold rating in a report released on Tuesday, Zacks.com reports. According to Zacks, DYNATRONICS CORP. is involved in the design, manufacture and sale of medical devices for therapeutic use by medical practitioners. DYNT has been the topic of several other []

Dakota Financial News | December 18, 2021

Zacks Investment Research Upgrades Dynatronics (NASDAQ:DYNT) to Buy

Zacks Investment Research upgraded shares of Dynatronics (NASDAQ:DYNT) from a hold rating to a buy rating in a research note published on Tuesday morning, Zacks.com reports. Zacks Investment Research currently has $1.25 price objective on the medical equipment providers stock. According to Zacks, DYNATRONICS CORP. is involved in the design, manufacture and sale of medical []

Transcript Daily | December 11, 2021

Read More 'DYNT' Stories Here

DYNT Price Returns

1-mo 5.40%
3-mo -2.59%
6-mo -39.83%
1-year -36.61%
3-year -55.71%
5-year -75.68%
YTD -29.00%
2021 23.46%
2020 -2.42%
2019 -69.59%
2018 -5.21%
2017 22.55%

Continue Researching DYNT

Want to see what other sources are saying about Dynatronics Corp's financials and stock price? Try the links below:

Dynatronics Corp (DYNT) Stock Price | Nasdaq
Dynatronics Corp (DYNT) Stock Quote, History and News - Yahoo Finance
Dynatronics Corp (DYNT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5901 seconds.